According to a systematic review [48], the most common laboratory abnormality mentioned in COVID-19 patients was hypoalbuminemia, followed by an increase in AST, ALT, GGT, ALP, and total bilirubin [48, 49], all of which are related to kidney, liver, and bile damage. This evidence concerns the gene GPT and COVID-19.